Expression of muscarinic M1 and M2 receptors in the anterior cingulate cortex associated with neuropathic pain

2017-06-292026-03-272017-06-292010Alberto Darío Ramírez González1090-3801doi:10.1016/j.ejpain.2010.02.007https://doi.org/10.1016/j.ejpain.2010.02.007https://repositorio.inprf.gob.mx/handle/123456789/4564engacceso cerradoAnimalsDisease Models, AnimalGene Expression Regulation/drug effectsGyrus Cinguli/drug effectsGyrus Cinguli/metabolismMaleMuscarinic Antagonists/pharmacologyPain/drug therapyPain/metabolismPain Measurement/methodsPeripheral Nervous System Diseases/drug therapyPeripheral Nervous System Diseases/metabolismRNA, Messenger/biosynthesisRatsRats, WistarReceptor, Muscarinic M1/antagonists and inhibitorsReceptor, Muscarinic M1/biosynthesisReceptor, Muscarinic M1/geneticsReceptor, Muscarinic M2/antagonists and inhibitorsReceptor, Muscarinic M2/biosynthesisReceptor, Muscarinic M2/geneticsScopolamine Hydrobromide/pharmacologyExpression of muscarinic M1 and M2 receptors in the anterior cingulate cortex associated with neuropathic painartículo1532-21499Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz901-910Inglaterra14Neuropathic painAcetylcholineMuscarinic receptorsAnterior cingulate cortexNociception